This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Pazoo, Inc. Set To Release First Pet Max Product: OxyMax H20

CEDAR KNOLLS, N.J., Jan. 15, 2013 /PRNewswire/ -- Pazoo, Inc. (OTCBB Symbol: PZOO (German WKN#: A1J3DK)) is pleased to announce that its Pet Max line of products for pets is set to be released ahead of schedule.  The first Pet Max product, the OxyMax H20, will be distributed to the largest private pet store chain in New England, Pet Life Stores, within the next 45 days. Pazoo expects to announce the release of 3 to 4 additional products from the Pet Max line by the second quarter of 2013.

OxyMax H20 is a physician formulated liquid containing oxygen that is easily dispensed through an eye dropper.  The liquid is mixed with an animal's everyday water and increases its energy by increasing the levels of oxygen in its blood.  OxyMax H20 also helps clean an animal's gums and teeth.  OxyMax H20 is safe for everyday use and has no known side effects.  Please see the product picture below as well as the label and ingredients.

(Logo: )

President of Pet Life, Pete Risano, said, "Here at Pet Life we are both honored and excited to be the first chain of stores to receive the Pet Max - OxyMax H2O and are looking forward to a long partnership with Pet Max."

CEO of Pazoo, Inc., David Cunic, said, "We are very excited about the release of OxyMax H20.  After the last several road shows and radio interviews, the buzz and the inquiries about our Pet Max line of products has been extremely positive.  We expect the OxyMax H20 product to be the start of many more successful products to come.  Here at Pazoo, we are all looking forward to getting the PetMax line in stores throughout the nation."

About Pazoo, Inc.:

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $95.18 1.64%
FB $117.43 -0.96%
GOOG $692.36 -0.84%
TSLA $232.32 -3.92%
YHOO $36.01 -1.42%


Chart of I:DJI
DOW 17,750.91 -140.25 -0.78%
S&P 500 2,063.37 -18.06 -0.87%
NASDAQ 4,763.2240 -54.37 -1.13%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs